The immunocompetence of Schwann cells

Muscle and Nerve

Volumn 37, Issue 1, 2008, Pages 3-13

  Hörste, Gerd Meyer Zu ^a   Hu, Wei ^a   Hartung, Hans Peter ^a   Lehmann, Helmar C ^a   Kieseier, Bernd C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antigen presentation; Charcot Marie Tooth disease; Experimental autoimmune neuritis; Guillain Barr syndrome; Inflammatory neuropathy; Schwann cells

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; FAS LIGAND; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYELIN; NITRIC OXIDE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; GUILLAIN BARRE SYNDROME; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LEPROSY; MAJOR HISTOCOMPATIBILITY COMPLEX; MYCOBACTERIUM LEPRAE; MYELINATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCHWANN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; CYTOKINES; HUMANS; IMMUNOCOMPETENCE; INFLAMMATION; NEUROIMMUNOMODULATION; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYRADICULONEUROPATHY; SCHWANN CELLS;

EID: 37749039724     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20893     Document Type: Review

References (137)

1. Abbas N, Zou LP, Pelidou SH, Winblad B, Zhu J. Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system. Autoimmunity 2000;32: 93-99.
2. Abromson-Leeman S, Bronson R, Dorf ME. Experimental autoimmune peripheral neuritis induced in BALB/c mice by myelin basic protein-specific T cell clones. J Exp Med 1995; 182:587-592.
3. Ahn M, Lee Y, Moon C, Jin JK, Matsumoto Y, Koh CS, et al. Upregulation of osteopontin in Schwann cells of the sciatic nerves of Lewis rats with experimental autoimmune neuritis. Neurosci Lett 2004;372:137-141.
4. Andorfer B, Kieseier BC, Mathey E, Armati P, Pollard J, Oka N, et al. Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J Neuroimmunol 2001;116:226-232.
5. Anzini P, Neuberg DH, Schachner M, Nelles E, Willecke K, Zielasek J, et al. Stractural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J Neurosci 1997;17:4545-4551.
6. Armati PJ, Pollard JD, Gatenby P. Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve 1990;13:106-116.
7. Berghoff M, Samsam M, Muller M, Kobsar I, Toyka KV, Kiefer R, et al. Neuroprotective effect of the immune system in a mouse model of severe dysmyelinating hereditary neuropathy: enhanced axonal degeneration following disruption of the RAG-1 gene. Mol Cell Neurosci 2005;28:118-127.
8. Bergsteinsdottir K, Kingston A, Mirsky R, Jessen KR. Rat Schwann cells produce interleukin-1. J Neuroimmunol 1991; 34:15-23.
9. Bergsteinsdottir K, Kingston A, Jessen KR. Rat Schwann cells can be induced to express major histocompatibility complex class II molecules in vivo. J Neurocytol 1992;21:382-390.
10. Bigbee JW, Yoshino JE, DeVries GH. Morphological and proliferative responses of cultured Schwann cells following rapid phagocytosis of a myelin-enriched fraction. J Neurocytol 1987;16:487-496.
11. Bonetti B, Valdo P, Stegagno C, Tanel R, Zanusso GL, Ramarli D, et al. Tumor necrosis factor alpha and human Schwann cells: signalling and phenotype modulation without cell death. J Neuropathol Exp Neurol 2000;59:74-84.
12. Bourde O, Kiefer R, Toyka KV, Hartung HP. Quantification of interleukin-6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction. J Neuroimmunol 1996;69:135-140.
13. Bromley SK, Burack WR, Johnson KG, Somersalo K, Sims TN, Sumen C, et al. The immunological synapse. Annu Rev Immunol 2001;19:375-396.
14. Calida DM, Kremlev SG, Fujioka T, Hilliard B, Ventura E, Constantinescu CS, et al. Experimental allergic neuritis in the SJL/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12. J Neuroimmunol 2000;107: 1-7.
15. Cambier JC, Littman DR, Weiss A. Antigen presentation to T lymphocytes. In: Janeway JCA, Travers P, Walport M, Shlomchik MJ, editors. Immunobiology. New York: Garland Publishing; 2001.
16. Carenini S, Maurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, et al. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J Cell Biol 2001;152:301-308.
17. Chen X, Oppenheim JJ, Howard OM. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice. J Leukoc Biol 2005;78:114-121.
18. Constable AL, Armati PJ, Toyka KV, Hartung HP. Production of prostanoids by Lewis rat Schwann cells in vitro. Brain Res 1994;635:75-80.
19. Constable AL, Armati PJ, Hartung HP. DMSO induction of the leukotriene LTC4 by Lewis rat Schwann cells. J Neurol Sci 1999;162:120-126.
20. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004;5: 975-979.
21. Coyle AJ, Gutierrez-Ramos JC. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol 2001;2:203-209.
22. Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 2006;117:289-300.
23. Deretzi G, Zou LP, Pelidou SH, Nennesmo I, Levi M, Wahren B, et al. Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination. J Autoimmun 1999;12:81-89.
24. Eylar EH, Toro-Goyco E, Kessler MJ, Szymanska I. Induction of allergic neuritis in rhesus monkevs. J Neuroimmunol 1982;3:91-98.
25. Felts PA, Smith KJ, Gregson NA, Hughes RA. Brain-derived neurotrophic factor in experimental autoimmune neuritis. J Neuroimmunol 2002;124:62-69.
26. Ford AL, Britton WJ, Armati PJ. Schwann cells are able to present exogenous mycobacterial hsp70 to antigen-specific T lymphocytes. J Neuroimmunol 1993;43:151-159.
27. Gabreels-Festen AA, Joosten EM, Gabreels FJ, Jennekens FG, Janssen-van Kempen TW. Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I). J Neurol Sci 1992;107:145-154.
28. Gabriel CM, Hughes RA, Moore SE, Smith KJ, Walsh FS. Induction of experimental autoimmune neuritis with peripheral myelin protein-22. Brain 1998;121:1895-1902.
29. Gadient RA, Otten U. Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia. Brain Res 1996;724:41-46.
30. Gold R, Toyka KV, Hartung HP. Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells. Cell Immunol 1995;165:65-70.
31. Gold R, Hartung HP, Lassmann H. T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci 1997;20:399-404.
32. Gold R, Archelos JJ, Hartung H-P. Mechanisms of immune regulation in the peripheral nervous system. Brain Pathol 1999;9:343-360.
33. Gold R, Stoll G, Kieseier BC, Hartung HP, Toyka KV. Experimental autoimmune neuritis. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. (vol. 2). Philadelphia: Elsevier Saunders; 2005.
34. Griffin JW, George R, Ho T. Macrophage systems in peripheral nerves. A review. J Neuropathol Exp Neurol 1993;52: 553-560.
35. Griffin JW, Sheikh K. The Guillain-Barré syndromes. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. (vol. 2). Philadelphia: Elsevier Saunders; 2005. p 2197-2220.
36. Hahn AF. Guillain-Barré syndrome. Lancet 1998;352:635-641.
37. Hahn AF, Hartung HP, Dyck PJ. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. (vol. 2). Philadelphia: Elsevier Saunders; 2005. p 2221-2254.
38. Harboe M, Aseffa A, Leekassa R. Challenges presented by nerve damage in leprosy. Lepr Rev 2005;76:5-13.
39. Hase A, Saito F, Yamada H, Arai K, Shimizu T, Matsumura K. Characterization of glial cell line-derived neurotrophic factor family receptor alpha-1 in peripheral nerve Schwann cells. J Neurochem 2005;95:537-543.
40. Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004;5:971-974.
41. Hoffman PM, Powers JM, Weise MJ, Brostoff SW. Experimental allergic neuritis. I. Rat strain differences in the response to bovine myelin antigens. Brain Res 1980;195:355-362.
42. Hu W, Ramacher M, Hartung H-P, Kieseier BC. Schwann cells express Toll-like receptors. J Neuroimmunol 2004;154: 48.
43. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-995.
44. Iwase T, Jung CG, Bae H, Zhang M, Soliven B. Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells. J Neurochem 2005;94:1488-1499.
45. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
46. Jung S, Gaupp S, Korn T, Kollner G, Hartung HP, Toyka KV. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization. J Neurosci Res 2004;75:524-535.
47. Kadlubowski M, Hughes RA. Identification of the neuritogen for experimental allergic neuritis. Nature 1979;277:140-141.
48. Kadlubowski M, Hughes RA. The neuritogenicity and encephalitogenicity of P2 in the rat, guinea-pig and rabbit. J Neurol Sci 1980;48:171-178.
49. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinken WE, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 1999;189:865-870.
50. Kiefer R, Funa K, Schweitzer T, Jung S, Bourde O, Toyka KV, et al. Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course. Am J Pathol 1996;148:211-223.
51. Kiefer R, Kieseier BC, Bruck W, Hartung HP, Toyka KV. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 1998;121:469-479.
52. Kiefer R, Kieseier BC, Stoll G, Hartung HP. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 2001;64:109-127.
53. Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 2004;30:131-156.
54. Kieseier BC, Hartung HP, Wiendl H. Immune circuitry in the peripheral nervous system. Curr Opin Neurol 2006;19: 437-445.
55. Kingston AE, Bergsteinsdottir K, Jessen KR, Van der Meide PH, Colston MJ, Mirsky R. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction. Eur J Immunol 1989;19:177-183.
56. Kobsar I, Berghoff M, Samsam M, Wessig C, Maurer M, Toyka KV, et al. Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1. Brain 2003;126:804-813.
57. Kobsar I, Hasenpusch-Theil K, Wessig C, Muller HW, Martini R. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A. J Neurosci Res 2005;81:857-864.
58. Kobsar I, Oetke C, Kroner A, Wessig C, Crocker P, Martini R. Attenuated demyelination in the absence of the macrophage-restricted adhesion molecule sialoadhesin (Siglec-1) in mice heterozygously deficient in P0. Mol Cell Neurosci 2006; 31:685-691.
59. Koehler NK, Martin R, Wietholter H. The antibody repertoire in experimental allergic neuritis: evidence for PMP-22 as a novel neuritogen. J Neuroimmunol 1996;71:179-189.
60. Koller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 2005;352:1343-1356.
61. Koller H, Schroeter M, Kieseier BC, Hartung HP. Chronic inflammatory demyelinating polyneuropathy - update on pathogenesis, diagnostic criteria and therapy. Curr Opin Neurol 2005;18:273-278.
62. Krammer PH. CD95's deadly mission in the immune system. Nature 2000;407:789-795.
63. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 1996;39:424-431.
64. Lassmann H, Fierz W, Neuchrist C, Meyermann R. Chronic relapsing experimental allergic neuritis induced by repeated transfer of P2-protein reactive T cell lines. Brain 1991;114: 429-442.
65. Lee H, Jo EK, Choi SY, Oh SB, Park K, Kim JS, et al. Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration. Biochem Biophys Res Commun 2006;350:742-747.
66. Lilje O, Armati PJ. The distribution and abundance of MHC and ICAM-1 on Schwann cells in vitro. J Neuroimmunol 1997;77:75-84.
67. Lilje O. The processing and presentation of endogenous and exogenous antigen by Schwann cells in vitro. Cell Mol Life Sci 2002;59:2191-2198.
68. Linington C, Lassmann H, Ozawa K, Kosin S, Mongan L. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur J Immunol 1992;22:1813-1817.
69. Linker R, Lee DH, Siglienti I, Gold R. Is there a role for neurotrophins in the pathology of multiple sclerosis? J Neurol 2007;254(suppl I):I33-I40.
70. Lisak RP, Skundric D, Bealmear B, Ragheb S. The role of cytokines in Schwann cell damage, protection, and repair. J Infect Dis 1997;176(suppl 2):S173-179.
71. Maenaka K, Jones EY. MHC superfamily structure and the immune system. Curr Opin Struct Biol 1999;9:745-753.
72. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 1995;11:281-286.
73. Martini R, Toyka KV. Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. Lancet Neurol 2004;3:457-465.
74. Mathey EK, Pollard JD, Armati PJ. TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci 1999;163:47-52.
75. Maurer M, Schmid CD, Bootz F, Zielasek J, Toyka KV, Oehen S, et al. Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants. Mol Cell Neurosci 2001;17:1094-1101.
76. Maurer M, Gold R. Animal models of immune-mediated neuropathies. Curr Opin Neurol 2002;15:617-622.
77. Maurer M, Muller M, Kobsar I, Leonhard C, Martini R, Kiefer R. Origin of pathogenic macrophages and endoneurial fibroblast-like cells in an animal model of inherited neuropathy. Mol Cell Neurosci 2003;23:351-359.
78. McCombe PA, Harness J, Pender MP. Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neuroimmunol 1999;97:60-69.
79. Medzhitov R, Janeway CJ. Innate immunity. N Engl J Med 2000;343:338-344.
80. Meyer zu Horste G, Nave KA. Animal models of inherited neuropathies. Curr Opin Neurol 2006;19:464-473.
81. Miletic H, Utermohlen O, Wedekind C, Hermann M, Stenzel W, Lassmann H, et al. P0(106-125) is a neuritogenic epitope of the peripheral myelin protein P0 and induces autoimmune neuritis in C57BL/6 mice. J Neuropathol Exp Neurol 2005;64:66-73.
82. Milner P, Lovelidge CA, Taylor WA, Hughes RA. P0 myelin protein produces experimental allergic neuritis in Lewis rats. J Neurol Sci 1987;79:275-285.
83. Miyamoto K, Oka N, Kawasaki T, Satoi H, Matsuo A, Akiguchi I. The action mechanism of cyclooxygenase-2 inhibitor for treatment of experimental allergic neuritis. Muscle Nerve 1999;22:1704-1709.
84. Miyamoto K, Miyake S, Schachner M, Yamamura T. Heterozygous null mutation of myelin P0 protein enhances susceptibilitv to autoimmune neuritis targeting P0 peptide. Eur J Immunol 2003;33:656-665.
85. Muller M, Stenner M, Wacker K, Ringelstein EB, Hickey WT, Kiefer R. Contribution of resident endoneurial macrophages to the local cellular response in experimental autoimmune neuritis. J Neuropathol Exp Neurol 2006;65:499-507.
86. Murata K, Dalakas MC. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy. Brain 2000;123:1660-1666.
87. Murwani R, Hodgkinson S, Armati P. Tumor necrosis factor alpha and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon gamma stimulation. J Neuroimmunol 1996;71:65-71.
88. Nobbio L, Gherardi G, Vigo T, Passalacqua M, Melloni E, Abbruzzese M, et al. Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease. Eur J Neurosci 2006; 23:1445-1452.
89. Oliveira RB, Oehoa MT, Sieling PA, Rea TH, Rambukkana A, Sarno EN, et al. Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of new damage in leprosy. Infect Immun 2003;71:1427-1433.
90. Oliveira RB, Sampaio EP, Aarestrup F, Teles RM, Silva TP, Oliveira AL, et al. Cytokines and Mycobacterium leprae induce apoptosis in human Schwann cells. J Neuropathol Exp Neurol 2005;64:882-890.
91. Pereira RM, Calegari-Silva TC, Hernandez MO, Saliba AM, Redner P, Pessolani MC, et al. Mycobacterium leprae induces NF-kappaB-dependent transcription repression in human Schwann cells. Biochem Biophys Res Commun 2005; 335:20-26.
92. Pollard JD, McCombe PA, Baverstock J, Gatenby PA, McLeod JG. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 1986;13:123-134.
93. Pollard JD, Baverstock J, McLeod JG. Class II antigen expression and inflammatory cells in the Guillain-Barré syndrome. Ann Neurol 1987;21:337-341.
94. Pollard JD. Chronic inflammatory demyelinating polyradiculoneuropathy. Curr Opin Neurol 2002;15:279-283.
95. Rambukkana A, Yamada H, Zanazzi G, Mathus T, Salzer JL, Yurchenco PD, et al. Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science 1998; 282:2076-2079.
96. Rambukkana A, Zanazzi G, Tapinos N, Salzer JL. Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells. Science 2002;296:927-931.
97. Rock KL,, York IA, Goldberg AL. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat Immunol 2004;5:670-677.
98. Rostami A, Burns JB, Brown MJ, Rosen J, Zweiman B, Lisak RP, et al. Transfer of experimental allergic neuritis with P2-reactive T-cell lines. Cell Immunol 1985;91:354-361.
99. Sabin TD, Swift TR, Jacobson RR. Leprosy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. (vol. 2). Philadelphia: Elsevier Saunders; 2005. p 2081-2108.
100. Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B, et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med 2001;194:677-684.
101. Samuel NM, Mirsky R, Grange JM, Jessen KR. Expression of major histocompatibility complex class I and class II antigens in human Schwann cell cultures and effects of infection with Mycobacterium leprae. Clin Exp Immunol 1987;68:500-509.
102. Sawant-Mane S, Piddlesden SJ, Morgan BP, Holers VM, Koski CL. CD59 homologue regulates complement-dependent cvtolysis of rat Schwann cells. J Neuroimmunol 1996;69:63-71.
103. Scherer SS, Kamholz J, Jakowlew SB. Axons modulate the expression of transforming growth factor-betas in Schwann cells. Glia 1993;8:265-276.
104. Schmid CD, Stienekemeier M, Oehen S, Bootz F, Zielasek J, Gold R, et al. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 2000;20:729-735.
105. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002;2:116-126.
106. Sheikh KA, Ho TW, Nachamkin I, Li CY, Cornblath DR, Asbury AK, et al. Molecular mimicry in Guillain-Barré syndrome. Ann NY Acad Sci 1998;845:307-321.
107. Skundric DS, Bealmear B, Lisak RP. Induced upregulation of IL-1, IL-1RA and IL-1R type I gene expression by Schwann cells. J Neuroimmunol 1997;74:9-18.
108. Skundric DS, Lisak RP, Rouhi M, Kieseier BC, Jung S, Hartung HP. Schwann cell-specific regulation of IL-1 and IL-1Ra during EAN: possible relevance for immune regulation at paranodal regions. J Neuroimmunol 2001;116:74-82.
109. Snyder DH, Stone SH, Raine CS. Attempts to induce chronic experimental allergic neuritis in strain 13 and Hartley guinea pigs. J Neuropathol Exp Neurol 1977;36:488-498.
110. Spierings E, de Boer T, Wieles B, Adams LB, Marani E, Ottenhoff TH. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogcnic mechanism of nerve damage in leprosy. J Immunol 2001;I66:5883-5888.
111. Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 2002;125:75-85.
112. Steinhoff U, Kaufmann SH. Specific lysis by CD8+ T cells of Schwann cells expressing Mycobacterium leprae antigens. Eur J Immunol 1988;18:969-972.
113. Stewart HJ, Rougon G, Dong Z, Dean C, Jessen KR, Mirsky R. TGF-betas upregulate NCAM and L1 expression in cultured Schwann cells, suppress cyclic AMP-induced expression of O4 and galactocerebroside, and are widely expressed in cells of the Schwann cell lineage in vivo. Glia 1995;15:419-436.
114. Stoll G, Schwendemann G, Heininger K, Kohne W, Hartung HP, Seitz R, Toyka KV. Relation of clinical, serological, morphological, and electrophysiological findings in galactocerebroside-induced experimental allergic neuritis. J Neurol Neurosurg Psychiatry 1986;49:258-264.
115. Stoll G, Schmidt B, Jander S, Toyka KV, Hartung HP. Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system. Ann Neurol 1991;30:147-155.
116. Stoll G, Jung S, Jander S, van der Meide P, Hartung HP. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 1993;45:175-182.
117. Suter U, Scherer SS. Disease mechanisms in inherited neuropathies. Nat Rev Neurosci 2003;4:714-726.
118. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
119. + currents in rat single myelinated nerve fibers. Intern Med 2000;39:123-127.
120. Tapinos N, Ohnishi M, Rambukkana A. ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nat Med 2006;12:961-966.
121. Taylor WA, Hughes RA. Experimental allergic neuritis induced in SJL mice by bovine P2. J Neuroimmunol 1985;8: 153-157.
122. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005;23:975-1028.
123. Tsai CP, Pollard JD, Armati PJ. Interferon-gamma inhibition suppresses experimental allergic neuritis: modulation of major histocompatibility complex expression of Schwann cells in vitro. J Neuroimmunol 1991;31:133-145.
124. Visan L, Visan IA, Weishaupt A, Hofstetter HH, Toyka KV, Hunig T, et al. Tolerance induction by intrathymic expression of P0. J Immunol 2004;172:1364-1370.
125. Vital A, Vital C, Julien J, Fontan D. Occurrence of active demyelinating lesions in children with hereditary motor and sensory neuropathy (HMSN) type I. Acta Neuropathol (Berl) 1992;84:433-436.
126. Wagner R, Myers RR. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 1996;73:625-629.
127. Watts C. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat Immunol 2004;5:685-692.
128. Weber F, Rudel R, Aulkemeyer P, Brinkmeier H. Anti-GM1 antibodies can block neuronal voltage-gated sodium channels. Muscle Nerve 2000;23:1414-1420.
129. Weerth S, Berger T, Lassmann H, Linington C. Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat. J Neuroimmunol 1999;95:157-164.
130. Wekerle H, Schwab M, Linington C, Meyermann R. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur J Immunol 1986;16:1551-1557.
131. Wohlleben G, Hartung HP, Gold R. Humoral and cellular immune functions of cytokine-treated Schwann cells. Adv Exp Med Biol 1999;468:151-156.
132. Wohlleben G, Ibrahim SM, Schmidt J, Toyka KV, Hartung HP, Gold R. Regulation of Fas and FasL expression on rat Schwann cells. Glia 2000;30:373-381.
133. Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-1775.
134. Yuki N, Taki T, Takahashi M, Saito K, Yoshino H, Tai T, et al. Molecular mimicry between GQ1b ganglioside and lipopoly-saccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994;36:791-793.
135. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 2001;49:712-720.
136. Yuki N. Carbohydrate mimicry: a new paradigm of autoimmune diseases. Curr Opin Immunol 2005;17:577-582.
137. Zou LP, Ljunggren HG, Levi M, Nennesmo I, Wahren B, Mix E, et al. P0 protein peptide 180-199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice. J Neurosci Res 2000;62:717-721.